108 related articles for article (PubMed ID: 15364711)
1. Visual fields in retinoblastoma survivors.
Abramson DH; Melson MR; Servodidio C
Arch Ophthalmol; 2004 Sep; 122(9):1324-30. PubMed ID: 15364711
[TBL] [Abstract][Full Text] [Related]
2. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
3. [Retinoblastoma regression patterns and results following chemo reduction and adjuvant therapy].
Xue K; Qian J; Yue H; Yuan YF; Zhang R
Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):625-30. PubMed ID: 22943868
[TBL] [Abstract][Full Text] [Related]
4. Functional results after treatment of retinoblastoma.
Desjardins L; Chefchaouni MC; Lumbroso L; Levy C; Asselain B; Bours D; Vedrenne J; Zucker JM; Doz F
J AAPOS; 2002 Apr; 6(2):108-11. PubMed ID: 11997807
[TBL] [Abstract][Full Text] [Related]
5. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
Bartuma K; Pal N; Kosek S; Holm S; All-Ericsson C
Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
[TBL] [Abstract][Full Text] [Related]
6. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
Kobylarz J; Piwowarczyk A; Romanowska-Dixon B; Balwierz W; Dłuzniewska A
Klin Oczna; 2006; 108(1-3):55-9. PubMed ID: 16883942
[TBL] [Abstract][Full Text] [Related]
7. Eye-preserving therapy in retinoblastoma: prolonged primary chemotherapy alone or combined with local therapy.
Shin JY; Kim JH; Yu YS; Khwarg SI; Choung HK; Shin HY; Ahn HS
Korean J Ophthalmol; 2010 Aug; 24(4):219-24. PubMed ID: 20714385
[TBL] [Abstract][Full Text] [Related]
8. Vitreoretinal complications of retinoblastoma treatment.
Tawansy KA; Samuel MA; Shammas M; Murphree AL
Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679
[TBL] [Abstract][Full Text] [Related]
9. Rhegmatogenous retinal detachment following treatment for retinoblastoma.
Saumya Pal S; Gopal L; Khetan V; Nagpal A; Sharma T
J Pediatr Ophthalmol Strabismus; 2010; 47(6):349-55. PubMed ID: 20055334
[TBL] [Abstract][Full Text] [Related]
10. Surgical repair of rhegmatogenous retinal detachment after treatment for retinoblastoma.
Baumal CR; Shields CL; Shields JA; Tasman WS
Ophthalmology; 1998 Nov; 105(11):2134-9. PubMed ID: 9818618
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
12. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
[TBL] [Abstract][Full Text] [Related]
13. [Intraocular retinoblastoma: new therapeutic options].
Imhof SM; Moll AC; Schouten-van Meeteren AY
Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2165-70. PubMed ID: 11727614
[TBL] [Abstract][Full Text] [Related]
14. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
15. Long-term visual outcome following chemoreduction for retinoblastoma.
Demirci H; Shields CL; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Nov; 123(11):1525-30. PubMed ID: 16286614
[TBL] [Abstract][Full Text] [Related]
16. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success.
Abramson DH; Schefler AC
Ophthalmology; 2004 May; 111(5):984-91. PubMed ID: 15121378
[TBL] [Abstract][Full Text] [Related]
17. [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma].
Lumbroso L; Doz F; Levy C; Dendale R; Vedrenne J; Bours D; Zucker JM; Asselain B; Desjardins L
J Fr Ophtalmol; 2003 Feb; 26(2):154-9. PubMed ID: 12660589
[TBL] [Abstract][Full Text] [Related]
18. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
Künkele A; Jurklies C; Wieland R; Lohmann D; Bornfeld N; Eggert A; Schulte JH
Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
[TBL] [Abstract][Full Text] [Related]
19. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
Wilson MW; Haik BG; Liu T; Merchant TE; Rodriguez-Galindo C
Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
[TBL] [Abstract][Full Text] [Related]
20. Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy.
Ghassemi F; Rahmanikhah E; Roohipoor R; Karkhaneh R; Faegh A
Pediatr Blood Cancer; 2013 Apr; 60(4):599-604. PubMed ID: 23034769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
